[1] Matsumoto M, Natsugoe S, Nakashima S,et al. Biological evaluation of undifferentiated carcinoma of the esophagus. Ann Surg Oncol, 2000,7:204-209. [2] Chow V, Yuen AP, Lam KY, et al. A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma. J Cancer Res Clin Oncol, 2001,127:59-63. [3] Harada H, Iwatsuki K, Ohtsuka M, et al. Abnormal desmoglein expression by squamous cell carcinoma cells. Acta Derm Venereol(Stockh), 1996, 76:417-420. [4] Krunic AL, Garrod DR, Madani S, et al. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype:actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.Br J Cancer, 1998,77:1275-1279. [5] Iwatsuki K, Han GW, Fukuti R, et al.Internalization of constitutive desmogleins with the subsequent induction of desmoglein 2 in pemphigus lesions.Br J Dermatol, 1999,140:35-43. [6] Simrak D, Cowley CM, Buxton RS, et al. Tandem arrangement of the closely linked desmoglein genes on human chromosome 18. Genomics, 1995, 25:591-594. [7] Tada H, Hatoko M, Tanaka A, et al. Expression of desmoglein 1 and plakoglobin in skin carcinomas. J Cutan Pathol, 2000, 27:24-29. [8] Miracco C, De Santi MM, Lio R, et al. Quantitatively evaluated ultrastructural findings can add to the differential diagnosis between keratoacanthoma and well differentiated squamous cell carcinoma. J Submicrosc Cytol Pathol, 1992,24:315-321. [9] Schwartz RA. Premalignant keratinocytic neoplasms.J Am Acad Dermatol, 1996,35(2 Pt 1):223-242. |